FDA NDC Directory · JSON-LD · Markdown

Cefadroxil

NDC 57237-097 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerRising Pharma Holdings, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA065349
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsCEFADROXIL (250 mg/5mL)
Marketing started20130425
Package count2

External sources

Source: openFDA. Public-domain (CC0).